Variants in LRRK2 are associated with increased risk for Parkinson’s and Crohn’s disease (CD), including a putative protective haplotype (N551K-R1398H) linked to reduced risk for both PD and CD [16–18]. This evidence concerns the gene LRRK2 and Parkinson disease.